The United States Centers for Disease Control and Prevention (CDC) announces that more than 10,000 cases of “breakthrough” COVID-19 infections have been diagnosed among vaccinated Americans. The CDC also asserts that the actual number of…

Recently released data show that the Moderna COVID-19 vaccine is effective among children ages 12 to 17. Data were collected from a clinical trial of more than 3,700 adolescents. Among those who received two doses of the Moderna vaccine, no…

A recent study published in the Journal of the American Dental Association finds that dentists are at lower risk for contracting SARS-CoV-2 than other healthcare providers such as nurses and physicians. Based on data collected from June…

The number of new COVID-19 infections in the United States hit a new low on May 20 with an average of fewer than 30,000 cases reported over the past 7 days. Over the past 2 weeks, new cases have fallen by more than 35%. Nearly 40% of…

The World Health Organization (WHO) announced that the number of deaths across the globe attributed to COVID-19 is most likely two times to three times higher than the official figure given. WHO suggested that the COVID-19 death toll in…

Ohio, Maryland, New York, and Oregon are offering lotteries worth millions of dollars to increase vaccination rates. On May 13, Ohio Governor Mike DeWine announced that Ohio residents ages 18 and older who receive a COVID-19 vaccination…

The United States Occupational Safety and Health Administration (OSHA) is set to implement an emergency temporary standard (ETS) to protect workers in light of the COVID-19 pandemic. While the content of the ETS is currently unknown, some…

The United States Department of Health and Human Services (HHS) will provide reimbursement to vaccine providers for underinsured patients whose health plans do not cover immunizations. The HHS will use funds from the federal COVID-19…

Recent results from a National Institutes of Health (NIH) study demonstrate that the body unleashes a large number of antibodies in response to infection with the novel coronavirus. Published in Science, the article looked at the antibodies…

A COVID-19 vaccine created through a partnership between Sanofi and GSK showed promising results in a Phase 2 clinical trial. A recombinant protein vaccine, it targets the SARS-CoV-2 spike protein, created via insect cells, with an antibody…